Intellectual Property Contracts & Agreements in the Unassigned Industry

2,665 Contracts & Agreements

Browse by Company

Recent Contracts

License Agreement with The Regents of the University of California (Invizyne Technologies Inc, Filed With SEC on April 17, 2024)
Technology License and Distribution Agreement, dated October 30, 2015, between the Registrant, as (Silvaco Group, Inc., Filed With SEC on April 12, 2024)
Transitional Trademark Cross License Agreement, dated as of March 31, 2024, by and between 3M Company and Solventum Corporation (Solventum Corp, Filed With SEC on April 4, 2024)
3M Trademark Use Agreement, dated as of March 31, 2024, by and between 3M Company and Solventum Corporation (Solventum Corp, Filed With SEC on April 4, 2024)
Intellectual Property Cross License Agreement, dated as of March 31, 2024, by and between 3M Company and Solventum Corporation (Solventum Corp, Filed With SEC on April 4, 2024)
Amendment to Technology License and Commercialization Agreement between Recruiter.com Group, Inc. and GoLogiq, Inc., dated March 28, 2024 (LOVARRA, Filed With SEC on April 3, 2024)
Trademark License Agreement, dated March 31, 2024, by and between General Electric Company and GE Infrastructure Technology LLC (GE Vernova LLC, Filed With SEC on April 2, 2024)
License Agreement, dated December 11, 2023, between Mereo BioPharma Group plc and ReproNovo SA (Mereo BioPharma Group plc, Filed With SEC on March 27, 2024)
Trademark License Agreement (ARES STRATEGIC INCOME FUND, Filed With SEC on March 14, 2024)
Amendment No. 12 to License Agreement, dated October 2, 2023, between MIL 21E, LLC and the Registrant (Prime Medicine, Inc., Filed With SEC on March 1, 2024)
License Agreement, between UL International Singapore Ltd., as Licensor, and ULSE Inc., as Licensee (UL Solutions Inc., Filed With SEC on February 29, 2024)
License Agreement, between UL International Singapore Ltd., as Licensor, and Underwriters Laboratories Inc., as Licensee (UL Solutions Inc., Filed With SEC on February 29, 2024)
License Agreement, between UL LLC, as Licensor, and ULSE Inc., as Licensee (UL Solutions Inc., Filed With SEC on February 29, 2024)
License Agreement, between UL LLC, as Licensor, and Underwriters Laboratories Inc., as Licensee (UL Solutions Inc., Filed With SEC on February 29, 2024)
Amendment No. 1 to Data Services and License Agreement, effective as of June 8, 2022, by and between Life360, Inc. and Placer Labs Inc (Life360, Inc., Filed With SEC on February 29, 2024)
Technology License and Commercialization Agreement between Recruiter.com Group, Inc. and GoLogiq, Inc., dated February 23, 2024 (LOVARRA, Filed With SEC on February 28, 2024)
Intellectual Property License Agreement, dated as of January 12, 2024, by and among Cementos Argos S.A., Summit Materials, Inc. and Argos North America Corp (Summit Materials, LLC, Filed With SEC on February 12, 2024)
License Agreement, dated January 16, 2024, by and between the Company and INmune Bio, Inc (Elevai Labs Inc., Filed With SEC on January 22, 2024)
Addendum to Domain License Agreement between HR Entertainment Ltd. and Happy Hour Solutions Ltd (High Roller Technologies, Inc., Filed With SEC on January 18, 2024)
Joint Development and License Agreement, by and between the Registrant and MedRx Co., Ltd., dated as of September 25, 2023 (Alto Neuroscience, Inc., Filed With SEC on January 12, 2024)
Exclusive License Agreement, by and between Dow Agrosciences LLC and Neuralstem, Inc., dated as of December 1, 2016 (Alto Neuroscience, Inc., Filed With SEC on January 12, 2024)
Patent and Know-How License Agreement, by and between the Registrant and Cerecor Inc. (k/n/a Avalo Therapeutics, Inc.), dated as of May 28, 2021 (Alto Neuroscience, Inc., Filed With SEC on January 12, 2024)
License Agreement, by and between the Registrant and Sanofi, dated as of May 18, 2021 (Alto Neuroscience, Inc., Filed With SEC on January 12, 2024)
Exclusive License Agreement With Equity, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated as of December 6, 2019, as amended... (Alto Neuroscience, Inc., Filed With SEC on January 12, 2024)
Secondary Index License Agreement (Valkyrie Bitcoin Fund, Filed With SEC on January 9, 2024)
Secondary Index License Agreement (Valkyrie Bitcoin Fund, Filed With SEC on January 8, 2024)
Index License Agreement (Valkyrie Bitcoin Fund, Filed With SEC on January 8, 2024)
License Agreement, by and between the Registrant and Shanghai Allist Pharmaceuticals Co., Ltd., dated June 29, 2021, as amended by Amendment No. 1, dated November 6, 2023 (ArriVent Biopharma, Inc., Filed With SEC on January 5, 2024)
Development and License Agreement, dated March 11, 2019, between the Lepu Biotech Co., Ltd. and the Registrant (CG Oncology, Inc., Filed With SEC on January 2, 2024)
Form of Index License Agreement (Valkyrie Bitcoin Fund, Filed With SEC on December 29, 2023)
License Agreement Amendment 8.30.23 (YOUNEEQAI TECHNICAL SERVICES, INC., Filed With SEC on December 22, 2023)
License Agreement Amendment 2.6.23 (YOUNEEQAI TECHNICAL SERVICES, INC., Filed With SEC on December 22, 2023)
Domain License Agreement between HR Entertainment Ltd. and Happy Hour Solutions Ltd (High Roller Technologies, Inc., Filed With SEC on December 20, 2023)
Estonia Gambling License issued to Happy Hour Solutions Limited dated November 8, 2021 (High Roller Technologies, Inc., Filed With SEC on December 20, 2023)
Domain Name License Agreement Between Spike Up Media AB and HR Entertainment Ltd (High Roller Technologies, Inc., Filed With SEC on December 20, 2023)
Amended and Restated Exclusive License Agreement by and between University of Southern California, and NeOnc Technologies, Inc (NEONC TECHNOLOGIES HOLDINGS, INC., Filed With SEC on December 18, 2023)
Trademark License Agreement, dated November 30, 2023, between Worthington Enterprises, Inc. and Worthington Steel, Inc (Worthington Steel, Inc., Filed With SEC on December 5, 2023)
WBS License Agreement, dated November 30, 2023, between Worthington Enterprises, Inc. and Worthington Steel, Inc (Worthington Steel, Inc., Filed With SEC on December 5, 2023)
Amendment No. 4, effective January 1, 2023, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (FibroBiologics Inc., Filed With SEC on November 28, 2023)
Amendment No. 3, effective October 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (FibroBiologics Inc., Filed With SEC on November 28, 2023)